Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
companyunderground
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» GSK, Theravance announce positive data from two phase III studies
GSK, Theravance announce positive data from two phase III studies
GSK, Theravance announce positive data from two phase III studies
Submitted by
admin
on June 11, 2014 - 9:06am
Source:
The Fly on the Wall
News Tags:
GSK
Theravance
COPD
Relvar Ellipta
Headline:
GSK, Theravance announce positive data from two phase III studies
Do Not Allow Advertisers to Use My Personal information
